Equillium (EQ) Non-cash Items (2018 - 2026)
Equillium (EQ) reported Non-cash Items of $3.9 million for Q1 2026, down 34.57% year-over-year from $6.0 million in Q1 2025, and down 2.8% quarter-over-quarter from $4.0 million in Q4 2025.
Equillium (EQ) Non-cash Items (2018 - 2026) Analysis & Trends
Equillium (EQ) has 9 years of Non-cash Items data on file, last reported at $3.9 million in Q1 2026.
- Non-cash Items for Q1 2026 came in at $3.9 million, down 34.57% year-over-year; the trailing twelve-month figure through Mar 2026 was $3.9 million (down 34.57% YoY), and the FY2025 annual result was $4.0 million, up 44.53% from the prior year.
- Non-cash Items slipped to $3.9 million in Q1 2026 per EQ's latest filing, from $4.0 million in the prior quarter.
- Over five years, Non-cash Items peaked at $13.6 million in Q1 2024 and troughed at $2000.0 in Q3 2022.
- A 5-year average of $4.0 million and a median of $3.3 million in 2023 frame the typical range for Non-cash Items.
- The sharpest annual moves came in 2022 and 2024: Non-cash Items slumped 99.83% in 2022, then soared 17656.18% in 2024.
- A 5-year view of Non-cash Items shows it stood at $2.5 million in 2022, then soared by 50.5% to $3.7 million in 2023, then slipped by 25.08% to $2.8 million in 2024, then jumped by 44.53% to $4.0 million in 2025, then fell by 2.8% to $3.9 million in 2026.
- Business Quant data shows EQ's Non-cash Items at $3.9 million in Q1 2026, $4.0 million in Q4 2025, and $8.4 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Equillium | 293.17 Mn | 232.78 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 3.93 Mn |
| Mar 31, 2026 | 3.93 Mn |
| Dec 31, 2025 | 4.05 Mn |
| Dec 31, 2025 | 4.05 Mn |
| Sep 30, 2025 | 8.40 Mn |
| Sep 30, 2025 | 8.40 Mn |
| Jun 30, 2025 | 2.70 Mn |
| Jun 30, 2025 | 2.70 Mn |
| Mar 31, 2025 | 6.01 Mn |
| Mar 31, 2025 | 6.01 Mn |
| Dec 31, 2024 | 2.80 Mn |
| Dec 31, 2024 | 2.80 Mn |
| Sep 30, 2024 | 5.15 Mn |
| Sep 30, 2024 | 5.15 Mn |
| Jun 30, 2024 | 19,000.00 |
| Jun 30, 2024 | 19,000.00 |
| Mar 31, 2024 | 13.57 Mn |
| Mar 31, 2024 | 13.57 Mn |
| Dec 31, 2023 | 3.74 Mn |
| Dec 31, 2023 | 3.74 Mn |